IT Minister KT Rama Rao laid the foundation stone for five projects involving a cumulative investment of Rs 1,100 crore and which have the potential to create employment to 3,000 people
The program also includes the State’s flagship initiative, Biopharma Hub, which aims at catalysing the bipharma sector
We have a good problem on hand. We are running out of space at the cluster,” he said adding that various developments and expansions happening now will add about 20 lakh sqft of space in the next years or so, said KTR
Currently, 30 lakh sqft is used by over 200 biotechnology, life sciences and pharmaceutical companies in Genome Valley, India’s first organised research and development cluster
Genome Valley has more plug-and-play facilities than all the clusters put together, he said adding that many contract research organisations are seeing huge growth opportunities
Telangana has been in the forefront in the vaccines development and its role has been highlighted during the Covid
Investments worth about Rs 2,500 crore by various companies including Biological E Limited and Indian Immunological to up the vaccine manufacturing capacity
Pharma company Hetero has announced Rs 750 crore in the sterile pharmaceutical products